Cited by 16Diabetes, Cardiovascular Risks, and LipoproteinsBariatric Surgery and OutcomesPharmacology and Obesity Treatment

A systematic review of commercial weight loss programmes’ effect on glycemic outcomes among overweight and obese adults with and without type 2 diabetes mellitus

Open access
Chaudhry, Z. W., Doshi, R. S., Mehta, A. K., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., Kalyani, R. R. +2 more·2016·Obesity Reviews

Abstract

Summary: Objective: We examined the glycemic benefits of commercial weight loss programmes as compared with control/education or counselling among overweight and obese adults with and without type 2 diabetes mellitus (T2DM). Methods: We searched MEDLINE, Cochrane Database of Systematic Reviews, and references cited by individual programmes. We included randomized controlled trials of ≥12 weeks duration. Two reviewers extracted information on study design, population characteristics, interventions, and mean changes in haemoglobin A1c and glucose. Results: We included 18 randomized controlled trials. Few trials occurred among individuals with T2DM. In this population, Jenny Craig reduced A1c at least 0.4% more than counselling at 12 months, Nutrisystem significantly reduced A1c 0.3% more than counselling at 6 months, and OPTIFAST reduced A1c 0.3% more than counselling at 6 months. Among individuals without T2DM, few studies evaluated glycemic outcomes, and when reported, most did not show substantial reductions. Discussion: Few trials have examined whether commercial weight loss programmes result in glycemic benefits for their participants, particularly among overweight and obese individuals without T2DM. Jenny Craig, Nutrisystem and OPTIFAST show promising glycemic lowering benefits for patients with T2DM, although additional studies are needed to confirm these conclusions. © 2016 World Obesity

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/obr.12423

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Commercially available weight loss programs have demonstrated short-term success in glycemic control, but continued success at 1 year is uncommon.

    “Commercially available weight loss programs have demonstrated short-term success in glycemic control, but continued success at 1 year is uncommon [11].”

    From Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study (2018) · cites this paper as [11]

    The Discussion (page unavailable) reports promising short-term A1c reductions for Nutrisystem and OPTIFAST and no significant 12-month reductions in trials of SlimFast and Atkins. But Jenny Craig did reduce A1c at 12 months, and the review says long-term trials are scarce. It therefore supports short-term benefits for some programs, not a general conclusion that continued success at one year is uncommon. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chaudhry, Z. W., Doshi, R. S., Mehta, A. K., Jacobs, D. K., Vakil, R. M., Lee, C. J., Bleich, S. N., Kalyani, R. R., Clark, J. M., & Gudzune, K. A.
Affiliations
  • Johns Hopkins University (US)
  • University of Maryland, Baltimore (US)
  • Rutgers, The State University of New Jersey (US)
Corresponding author
Chaudhry, Z. W.
Venue
Obesity Reviews
Publisher
Wiley
Published
2016-05-26
Volume
17
Issue
8
Pages
758-769
ISSN
  • 1467-7881 (ISSN-L)
  • 1467-789X
OpenAlex
W2408334521
Cited by
16
References
52
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2021: 3 · 2020: 3 · 2018: 3 · 2017: 3 · 2016: 1
FWCI
0.34
Type
journal article
Language
en
Open access
Locations
  • Obesity Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Center for Advancing Translational Sciences (NCATS) (TL1TR001078)
  • NIDDK (P30DK079637, (DK093583)
  • NHLBI (K01HL096409, K23HL116601)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
Keywords
glycemic control, type 2 diabetes, overweight, obesity, HbA1c, nutrition counseling, OPTIFAST, weight management interventions
MeSH terms
Blood Glucose, Diabetes Mellitus, Type 2, Diet, Reducing, Humans, Obesity, Exercise, Randomized Controlled Trials as Topic, Treatment Outcome, Risk Assessment, Overweight, Weight Reduction Programs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review